Open Access
Research Paper
Peer Reviewed

Paper Title

RETROSPECTIVE RECORD BASED STUDY ON PRESCRIBING PATTERN AND DRUG UTILIZATION PATTERN ON ACUTE CORONARY SYNDROME PATIENTS AT TERTIARY CARE HOSPITAL MANDYA

Article Identifiers

Registration ID: IJNRD_306052

Published ID: IJNRD2505010

: Click Here to Get

Keywords

Acute coronary syndrome, NSTEMI, Antiplatelets

Abstract

Acute Coronary Syndrome (ACS) is one of the major causes of morbidity and mortality in developing countries. Antiplatelet, antihypertensive and dyslipidemia therapy is the main stay of treatment for patients with acute coronary syndrome. Present study had been conducted to evaluate the prescribing pattern and drug utilization pattern on acute coronary syndrome patients. Aim: To describe the prescription and drug utilization pattern in patients with Acute Coronary Syndrome and to compare proportion of Acute Coronary Syndrome according to the demographic data and risk factors. Methodology: This was retrospective record-based study on prescribing pattern and drug utilization pattern on acute coronary syndrome patients admitted at general medicine department of MIMS, Mandya. The required data were collected from 111 cases based on inclusion criteria. A well-designed data collection form was used for collecting the details. The obtain information were documented and subjected to suitable statistical method. Result: Total 111 prescriptions with acute coronary syndrome were collected. Out of 111 cases, 29.72% where 51-60 years in that males were more prone to ACS. We divided 111 patients based on their smoking and alcoholic habit. 38 patients (34.23%) were found to be smoker, 27 patients (24.32%) were alcoholic. NSTEMI was the most commonly observed type of ACS. The most commonly prescribed antiplatelet was found to be Aspirin, the commonly prescribed dyslipedimic drug was found to be Atorvastatin. The most widely prescribed drugs were Aspirin, Atorvastatin and Clopidogrel followed by antihypertensive such as Enalapril. Hypertension was most commonly observed co- morbid condition with ACS. Conclusion: Our study concludes that Acute Coronary Syndrome is commonly seen in males at the age group of 51-60 years. Hypertension and diabetes were the most common co morbidity and mostly prescribed class of drug was found to be antiplatelets and dyslipidemic agents

How To Cite (APA)

Dr. Ajay Gopinath, Divya S, Guptha PH, & Hithaishi BR (May-2025). RETROSPECTIVE RECORD BASED STUDY ON PRESCRIBING PATTERN AND DRUG UTILIZATION PATTERN ON ACUTE CORONARY SYNDROME PATIENTS AT TERTIARY CARE HOSPITAL MANDYA. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 10(5), a77-a83. https://ijnrd.org/papers/IJNRD2505010.pdf

Issue

Other Publication Details

Paper Reg. ID: IJNRD_306052

Published Paper Id: IJNRD2505010

Downloads: 000121997

Research Area: Science and Technology

Author Type: Indian Author

Country: -, -, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2505010.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2505010

About Publisher

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

Copyright & License

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.

You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.
CC OpenContant

Publication Timeline

Peer Review
Through Scholar9.com Platform

Article Preview: View Full Paper

Call For Paper

Call For Paper - Volume 10 | Issue 11 | November 2025

IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.

IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.

Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.

How to submit the paper?

You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.


For more details, refer to the official notice: UGC Public Notice


Submit Paper Online

Important Dates for Current issue

Paper Submission Open For: November 2025

Current Issue: Volume 10 | Issue 11 | November 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 30-Nov-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details

Approval, Licenses and Indexing: More Details